Major breakthrough in the mechanism of myelin formationNovember 03, 2006The group of Dr. Michel Cayouette, researcher at Institut de recherches cliniques de Montréal (IRCM), and Dr. Jonah Chan, collaborator at the University of Southern California, will publish in the next issue of the prestigious scientific journal Science, the results of their study that could have a major impact on the treatment of diseases such as multiple sclerosis, and peripheral neuropathies. At a basic level, our nervous system is like a collection of wires that transmit electrical signals encoding our thoughts, feelings, and actions, both conscious and unconscious. The connections in our brain are formed by neurons that extend to each other and to muscles long wires called axons. Just as an electrical wire needs insulation, our axons require an insulating sheath (myelin) that helps to propagate the electrical signal and maximize the efficiency and velocity of these signals in our brain and body. It is this property (myelination) that facilitates the long-distance communication in our nervous system across junctions called synapses, such that a thought can result in the movement of a finger or a toe. Diseases and injury that compromise the integrity of myelin such as multiple sclerosis, or peripheral neuropathies, have dramatic consequences like paralysis, uncoordinated movements, and neuropathic pain. The discovery reported in this study sheds light on the mechanisms that control how myelin is formed during development of the nerves. The article, which will be published in the November 3rd issue of Science, constitutes an important step forward in our understanding of the process of myelination, and opens the way to new research in this field. More specifically, the study showed that a protein called Par-3 is at the base of the myelination process. This protein becomes localized to one side of the myelin-forming cells called Schwann cell, upon contact with the axon that is to be myelinated. Par-3 acts as a sort of molecular scaffold to set-up an "organizing centre", which brings together key proteins essential for myelination, in particular a receptor for a molecule secreted by the neurons. The scientists found that when they disrupted this organizing centre, cells could not form myelin normally. Importantly, their discovery demonstrates that Schwann cells need to become polarized so that they know which side of the cell is in contact with the axon so that they can initiate wrapping and bring essential molecules to this critical interface. These studies open the way to new research, which should help to identify other components that are recruited at the organizing centre set-up by Par-3. Importantly, in conditions such as multiple sclerosis or after injury, it is believed that Schwann cells could be used to re-myelinate axons. But so far this approach has proved to be relatively inefficient. Therefore, these experiments bring about the possibility that manipulating the Par-3 pathway in Schwann cells might allow for more efficient re-myelination of damaged or diseased nerves.
Institut de recherches cliniques de Montreal | |||||||||||||||||||||
|
Related Myelin Current Events and Myelin News Articles Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and Würzburg have been able to visualize inflammatory tissue damage, most of which had remained unrecognized up to now, with the aid of a new contrast medium, Gadofluorine M, in magnetic resonance imaging. MIT identifies cells for spinal-cord repair A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries. Statins have unexpected effect on pool of powerful brain cells Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University of Rochester Medical Center have found. The new findings shed light on a long-debated potential role for statins in the area of dementia. Best treatment for MS may depend on disease subtype Animal studies by University of Michigan scientists suggest that people who experience the same clinical signs of multiple sclerosis (MS) may have different forms of the disease that require different kinds of treatment. Resuscitation technique after brain injury may do more harm than good The current standard practice of giving infants and children 100 percent oxygen to prevent brain damage caused by oxygen deprivation may actually inflict additional harm, researchers at UT Southwestern Medical Center have found. Human stem cells show promise against fatal children's diseases Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell. Chemotherapy causes delayed severe neural damage Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors. Promising new nanotechnology for spinal cord injury A spinal cord injury often leads to permanent paralysis and loss of sensation below the site of the injury because the damaged nerve fibers can't regenerate. The nerve fibers or axons have the capacity to grow again, but don't because they're blocked by scar tissue that develops around the injury. Experimental MS drug shows promise, offers new window on disease A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial. NIH scientists detect fatal copper disorder at birth A test developed by NIH scientists could greatly extend the survival of infants with Menkes disease, a rare, otherwise fatal disorder of copper metabolism. More Myelin Current Events and Myelin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||